Accelerated diabetic glomerulopathy in galectin‐3/AGE receptor 3 knockout mice
Open Access
- 1 November 2001
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 15 (13) , 2471-2479
- https://doi.org/10.1096/fj.01-0006com
Abstract
Several molecules were shown to bind advanced glycation end products (AGEs) in vitro, but it is not known whether they all serve as AGE receptors and which functional role they play in vivo. We inves...Keywords
This publication has 32 references indexed in Scilit:
- The Role of Galectin-3 in Endocytosis of Advanced Glycation End Products and Modified Low Density LipoproteinsBiochemical and Biophysical Research Communications, 2001
- Differential expression of renal AGE-receptor genes in NOD mice: Possible role in nonobese diabetic renal diseaseKidney International, 2000
- Advanced glycation end product receptor interactions on microvascular cells occur within caveolin‐rich membrane domainsThe FASEB Journal, 2000
- Role of galectin-3 as a receptor for advanced glycosylation end productsKidney International, 2000
- N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene ExpressionJournal of Biological Chemistry, 1999
- Regulation of Cellular Adhesion to Extracellular Matrix Proteins by Galectin-3Biochemical and Biophysical Research Communications, 1998
- Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix.Journal of Clinical Investigation, 1997
- Expression of α(IV) Chains in Alport s Syndrome and Its Correlation with Ultrastructural and Genetic DataPublished by S. Karger AG ,1997
- Protein glycation in the kidney: Role in diabetes and agingKidney International, 1996
- Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathyKidney International, 1994